![Medscape on Twitter: "👍 JUST IN: FDA approves glucose-lowering drug liraglutide for patients as young as 10, making it the first noninsulin drug approved for treating pediatric #T2D in almost 20 years. Medscape on Twitter: "👍 JUST IN: FDA approves glucose-lowering drug liraglutide for patients as young as 10, making it the first noninsulin drug approved for treating pediatric #T2D in almost 20 years.](https://pbs.twimg.com/media/D9WLPLmXYAA-Sko.jpg)
Medscape on Twitter: "👍 JUST IN: FDA approves glucose-lowering drug liraglutide for patients as young as 10, making it the first noninsulin drug approved for treating pediatric #T2D in almost 20 years.
![PDF) Liraglutide for Weight Management: A Critical Review of the Evidence: Review: Liraglutide for Weight Management PDF) Liraglutide for Weight Management: A Critical Review of the Evidence: Review: Liraglutide for Weight Management](https://i1.rgstatic.net/publication/309891199_Liraglutide_for_Weight_Management_A_Critical_Review_of_the_Evidence_Review_Liraglutide_for_Weight_Management/links/5831356808ae102f0731d400/largepreview.png)
PDF) Liraglutide for Weight Management: A Critical Review of the Evidence: Review: Liraglutide for Weight Management
![Novo Nordisk settles allegations its sales reps obscured Victoza's risks - MM+M - Medical Marketing and Media Novo Nordisk settles allegations its sales reps obscured Victoza's risks - MM+M - Medical Marketing and Media](https://www.mmm-online.com/wp-content/uploads/sites/2/2018/07/victoza3pensopen_786697-6.jpg)